Get the Stockscreener App
2.28
25.00%
-0.76
After Hours:
2.23
-0.05
-2.19%
Alaunos Therapeutics Inc stock is traded at $2.28, with a volume of 1.31M.
It is down -25.00% in the last 24 hours and up +98.26% over the past month.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$3.04
Open:
$2.83
24h Volume:
1.31M
Relative Volume:
0.03
Market Cap:
$5.79M
Revenue:
$3,000
Net Income/Loss:
$-4.11M
P/E Ratio:
-1.0513
EPS:
-2.1688
Net Cash Flow:
$-3.23M
1W Performance:
-13.31%
1M Performance:
+98.26%
6M Performance:
-17.39%
1Y Performance:
-15.87%
1-Day Range:
$2.18
$2.855
1-Week Range:
$2.18
$3.49
52-Week Range:
$0.719
$4.50
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
501 E LAS OLAS BLVD, FORT LAUDERDALE
Compare TCRT vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.28 | 5.79M | 3,000 | -4.11M | -3.23M | -2.1688 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
GOA Therapeutics Launches $300 Million Stock Offerings to Advance First in Class Drug Candidate for Acute Alcohol Intoxication - Yahoo Finance
TCRT Stock Erupts As Alaunos Lands Velaris Deal And Cash - StocksToTrade
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Form 13D/A Alaunos Therapeutics For: 15 October By Investing.com - Investing.com Nigeria
Two 9.99% holders agree to back merger votes in Alaunos (TCRT)'s conditional repurchase deal. - Stock Titan
Following a roughly $350M financing, Fairmount reports a stake in Alaunos (TCRT). - Stock Titan
TCRT Stock Explodes After Velaris Deal And $350M Raise - StocksToTrade
Alaunos Therapeutics Acquires Velaris Therapeutics, Secures $350M Private Placement - citybiz
Alaunos Therapeutics Acquires Velaris Therapeutics, Secures $350 Million Private Placement to Advance Pulmonary Hypertension Pipeline - Quiver Quantitative
Alaunos completes Velaris acquisition, raises $350 million By Investing.com - Investing.com UK
Alaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates - Kalkine
Alaunos Therapeutics (TCRT) director Jaime Vieser receives 22,669 shares in lieu of board fees. - Stock Titan
Board fees are paid in 20,990 shares to Alaunos Therapeutics (TCRT) director Michael Allen Jerman. - Stock Titan
For board fees, Alaunos Therapeutics (TCRT) issues 21,829 shares to director Robert W. Postma. - Stock Titan
After two share sales, Sanjiv Patel proposes another at Relay Therapeutics (RLAY). - Stock Titan
To cover taxes, Definium Therapeutics (DFTX) medical chief sells 10,853 shares. - Stock Titan
Alaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates - kalkine.ca
Alaunos Therapeutics Announces New Registered Direct Offering - The Globe and Mail
Alaunos Therapeutics Announces New Registered Direct Offering - TipRanks
C4 Therapeutics (NASDAQ: CCCC) CFO logs RSU shares, withholds stock for taxes - Stock Titan
Alaunos Therapeutics prices registered direct offering to raise ~$1.12 million - TradingView
Alaunos Therapeutics raises $1.12M in registered direct offering - Investing.com
Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules - manilatimes.net
TCRT Stock Pops On Volatile Spike As Traders Circle - StocksToTrade
TCRT Stock Spikes On Heavy Volume As Traders Hunt Volatility - timothysykes.com
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
TCRT Stock Sees Volatile Spike As Traders Target Momentum - timothysykes.com
TCRT Stock Spikes On Heavy Volume As Traders Hunt Volatility - Timothy Sykes
Alaunos Therapeutics raises $1.12M in registered direct offering By Investing.com - Investing.com India
Trevi Therapeutics (TRVI) director sells 39,473 shares under trading plan - Stock Titan
Alaunos Therapeutics (TCRT) Holds Firm at $1.56 as Buyers Defend the Lower RangeMoving Average Crossovers - siam.in
Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportMcClellan Oscillator - siam.in
Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportPrice Target - careplusvn.com
Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportSentiment Shift - dars.gov.et
Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayCall Resistance - vinanet.vn
Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayIV Crush Alert - dars.gov.et
Alaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest SessionAnnual Report - vinanet.vn
Alaunos (TCRT) EPS and Revenue: EPS Does Not Reach the Reported Estimate; Price Reaction: The Session Ends Near the Prior LevelAnalyst Coverage Count - vinanet.vn
4D Molecular Therapeutics (NASDAQ: FDMT) legal chief sells 3,270 shares - Stock Titan
Ziopharm: Q2 Earnings Snapshot - KTVB
Alaunos Therapeutics, Inc. Q2 2026: Revenue $0K, Net loss $988K, EPS $(0.41) — 10-Q Summary - TradingView
Alaunos Therapeutics (TCRT) warns on cash runway, Nasdaq compliance and losses - Stock Titan
Alaunos Therapeutics (TCRT) CEO granted 4,363 shares in lieu of cash salary - Stock Titan
Alaunos Therapeutics (TCRT) Holds Flat at $1.99 as Key Support and Resistance Levels Come into FocusTWAP Entry - dars.gov.et
Enterprise value to EBITDA forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Alaunos Therapeutics Inc (TCRT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alaunos Therapeutics (TCRT) Shows Modest Decline Amid Tight Range TradingVolume Breakout Ideas - careplusvn.com
Alaunos Therapeutics (TCRT) Shows Modest Decline Amid Tight Range TradingBearish Pattern Stocks - vinanet.vn
Avoro lifts Scribe (NASDAQ: SCTX) stake to 3.09M shares - Stock Titan
CEO Holger Weis takes Alaunos Therapeutics, Inc. (TCRT) stock instead of salary - Stock Titan
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.09%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):